"I would hope they have some baseline data in order to alter dosing strategies to improve effectiveness."
I understand what you're saying and I think it lines up nicely with the writers intent. But I believe that rather than developing the baseline effectiveness data with noses, the data exists from the B-CV trial and that "Ongoing efforts are focused on dosing strategies" doesn't indicate that there are ongoing trials being conducted.....just that the issue of dosing is being considered.
Saying the words "ongoing in vivo testing" just isn't all that difficult. IF that's what is happening.
News 
Market Data 
Discover 
